Files in This Item:


Title: Seroprevalence of mumps before inclusion of mumps vaccination in the Iranian Expanded Programme on Immunization
Authors: Avijgan, M.
Habibian, R.
Kheiri, S.
Issue Date: 2009
Language: English
Abstract: The current target groups for measles, mumps and rubella vaccination in the Islamic Republic of Iran are children at 12 months and 4-6 years. A study of the age-specific seroprevalence of antibodies against mumps in children aged 3-18 years in Shahrekord aimed to establish the need for booster vaccinations to cover non-immune children. Of 338 children, 19.8% were seronegative. Age-specific seronegativity was 33.3%, 20.5% and 4.6% in age groups 7-11, 12-14 and 15-18 years respectively. To obtain herd immunity, we suggest that for the next 5 years children aged 7-11 years entering guidance school are selected as the main group for vaccination
Description: 295-301
Keywords: Mumps Vaccine
Immunization, Secondary
Seroepidemiologic Studies
Cross-Sectional Studies
Immunoglobulin G
Age Factors
Enzyme-Linked Immunosorbent Assay
Subject: Mumps
ISSN: 1020-3397
Other Identifiers:
Appears in Collections:EMRO Journal Articles (EMHJ)

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.